| Financial Year |
March 31 2023 |
| Monetary Funds |
8,951,286,159.78 |
| Held-for-trading Financial Assets |
909,539,766.05 |
| Notes Receivable |
5,921,890.56 |
| Accounts Receivable |
1,633,037,132.18 |
| Advances to Suppliers |
198,553,566.16 |
| Other Receivables |
192,744,067.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
18,574,060.70 |
| Inventories |
1,971,962,984.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
208,780,260.07 |
| Other Current Assets |
75,470,671.16 |
| Total Current Assets |
14,147,296,497.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
137,403,472.89 |
| Long-term Equity Investment |
533,767,256.92 |
| Investment Properties |
-- |
| Fixed Assetes |
1,487,623,569.06 |
| Under-construction Projects |
38,411,904.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
759,993,691.82 |
| R&D expenses |
-- |
| Goodwill |
279,961,127.90 |
| Long-Term Deferred and Prepaid Expenses |
122,776,546.49 |
| Deferred Income Tax Assets |
258,672,604.77 |
| Other Non-Current Assets |
351,036,033.02 |
| Sub-Total of Non-Current Assets |
6,026,626,922.66 |
| Total Assets |
20,173,923,420.51 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
5,009,270,434.59 |
| Accounts Received In Advance |
194,594,780.07 |
| Employee Compensation Payable |
33,719,649.49 |
| Taxes Payable |
110,987,232.96 |
| Interest Payable |
-- |
| Dividend Payable |
3,908,684.71 |
| Other payables |
562,634,755.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
140,997,845.27 |
| Other Current Liabilities |
21,416,758.88 |
| Sub-Total of Current Liabilities |
6,631,339,061.42 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,816,964.23 |
| Deferred Income Tax Liabilities |
133,032,943.65 |
| Other Non-Current Liabilities |
93,527,973.96 |
| Sub-Total of Non-Current Liabilities |
2,087,696,120.22 |
| Total Liabilities |
8,719,035,181.64 |
| Paid-In Capital(Or Share Stock) |
1,867,000,000.00 |
| Capital Surplus |
4,400,599,848.34 |
| Surplus Reserve |
720,266,061.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,016,292,732.96 |
| Minority Stockholder's Interest |
456,731,957.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,998,156,280.88 |
| Owner's Equity（Stockholder's Equity） |
11,454,888,238.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,173,923,420.51 |
